[Federal Register Volume 77, Number 4 (Friday, January 6, 2012)]
[Notices]
[Pages 783-784]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-18]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Notice of Availability for Exclusive, Non-Exclusive, or 
Partially-Exclusive Licensing of an Invention Concerning a Method and 
Device for Detection of Bioavailable Drug Concentration in a Fluid 
Sample

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The invention provides a method for the controlled delivery of 
a drug as a function of bioavailable drug concentration, a sensor 
device for detecting bioavailable drug concentration, and a delivery 
device that controls delivery of the drug based on the real-time 
detection of bioavailable drug concentration. Announcement is made of 
the availability for licensing of the invention set forth in 
International Patent Application No. PCT/US2009/060852 entitled, 
``Method and Device for Detection of Bioavailable Drug Concentration in 
a Fluid Sample,'' filed on October 15, 2009 (which claims the benefit 
of U.S. Provisional Patent Application Serial No. 651/105,604 filed 
October 15, 2008). The United States Government, as represented by the 
Secretary of the Army, has rights to this invention. U.S. and selected 
foreign rights are available.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research and Technology Applications (ORTA), (301) 619-
6664, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention relates to the method of 
electrochemical detection of bioavailable drug concentration intended 
to be used to modify the

[[Page 784]]

delivery rate of the drug to a patient during real-time.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2012-18 Filed 1-5-12; 8:45 am]
BILLING CODE 3710-08-P